Angiogenesis measured by expression of CD34 antigen in lymph nodes of patients with non-Hodgkin's lymphoma

Folia Histochemica et Cytobiologica

Volumn 42, Issue 4, 2004, Pages 241-243

  Mazur, Grzegorz ^a   Wróbel, Tomasz ^a   Dziegiel, Piotr ^a   Jeleń, Michał ^a   Kuliczkowski, Kazimierz ^a   Zabel, Maciej ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Angiogenesis; Microvessel density; Non Hodgkin's lymphoma

Indexed keywords

ANGIOGENESIS INHIBITOR; ANTIBODY; CD34 ANTIGEN; EOSIN; FORMALDEHYDE; HEMATOXYLIN; PARAFFIN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER CLASSIFICATION; CANCER GRADING; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; FEMALE; HEMATOLOGY; HISTOPATHOLOGY; HOSPITAL DEPARTMENT; HUMAN; HUMAN TISSUE; LYMPH NODE; MALE; MEDICAL SCHOOL; MICROVASCULATURE; NONHODGKIN LYMPHOMA; STATISTICAL ANALYSIS; TISSUE FIXATION; TISSUE SECTION; TUMOR VASCULARIZATION;

EID: 8344261408     PISSN: 02398508     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Aguayo A, Kantarjian H, Manshouri T, Gidel C, Estey E, Thomas D, Koller C, Estrov Z, O'Brien S, Keating M, Freireich E, Albitar M (2000) Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes. Blood 96: 2240-2245
2. Arias V, Soares FA (2000) Vascular density (tumor angiogenesis) in non-Hodgkin's lymphomas and florid follicular hyperplasia: a morphometric study. Leuk Lymphoma 40: 157-166
3. Bairey O, Zimra Y, Kaganovsky E, Shaklai M, Okon E, Rabizadeh E (2000) Microvessel density in chemosensitive and chemoresistant diffuse large B-cell lymphomas. Med Oncol 17: 314-318
4. Fina L, Molgaard H, Robertson D, Bradley NJ, Monaghan P, Delia D, Sutherland DR, Baker MA, Greaves MF (1990) Expression of the CD34 gene in vascular endothelial cells. Blood 75: 2417-2420
5. Folkman J (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1: 27-31
6. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML, Delsol G, De Wolf-Peeters C, Falini B, Gatter KC (1994) A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 84: 1361-1392
7. Hussong JW, Rodgers GM, Shami PJ (2000) Evidence of increased angiogenesis in patients with acute myeloid leukemia. Blood 95: 309-313
8. Juczewska M, Chyczewska E, Naumnik W, Chyczewski L, Niklinska W, Rogalewska A, Kowalczuk O, Niklinski J (2001) Endothelial cells and angiogenesis intensity in lung cancer. Folia Histochem Cytobiol 39: 253-258
9. Lister TA, Crowdther D (1990) Staging for Hodgkin's disease. Semin Oncol 17: 696-703
10. Mangi MH, Newland AC (2000) Angiogenesis and angiogenic mediators in haematological malignancies. Br J Haematol 111: 43-51
11. Miettinen M, Lindenmayer A, Chaubal A (1994) Endothelial cell markers CD31, CD34, and BNH9 antibody to H- and Y-antigens evaluation of their specificity and sensitivity in the diagnosis of vascular tumors and comparison with von Willibrand factor. Mod Path 7: 82-85
12. Perez-Atayde AR, Sallan SE, Tedrow U (1997) Spectrum of tumor angiogenesis in bone marrow of children with acute lymphoblastic leukemia. Am J Pathol 150: 815-821
13. Ribatti D, Vacca A, Marzullo A, Nico B, Ria R, Roncali L, Dammacco F (2000) Angiogenesis and mast cell density with tryptase activity increase simultaneously with pathological progression in B-cell non-Hodgkin's lymphomas. Int J Cancer 15: 171-175
14. Ribatti D, Vacca A, Nico B, Fanelli L, Roncali L, Dammacco F (1996) Angiogenesis spectrum in the stroma of B cell NHL. An immunohistochemical and ultrastructure study. Eur J Haematol 56: 45-53
15. Ridell B, Norrby K (2001) Intratumoral microvascular density in malignant lymphomas of B-cell origin. APMIS 109: 66-72
16. Salven P, Teerenhovi L, Joensuu H (1997) A high pretreatment serum vascular endothelial growth factor concentration is associated with poor outcome in non-Hodgkin's lymphoma. Blood 90: 3167-3172
17. Schaerer L, Schmid MH, Mueller B, Dummer RG, Burg G, Kempf W (2000) Angiogenesis in cutaneous lymphoproliferative disorders: microvessel density discriminates between cutaneous B-cell lymphomas and B-cell pseudolymphomas. Am J Dermatopathol 22: 140-143
18. Usnarska-Zubkiewicz L, Mazur G, Wróbel T, Poreba M, Kuliczkowski K (2003) Expression of serum vascular endothelial growth factor correlates with clinical outcome in multiple myeloma (in Polish). Pol Arch Med Wewn 110: 719-724
19. Vacca A, Ribatti D, Roncalli L, Dammacco F (1995) Angiogenesis in B cell lymphoproliferative diseases. Biological and clinical studies. Leuk Lymphoma 20: 27-38
20. Wadleigh M, Niedzwiecki D, Davis P, Payne N, Sen F, Mann KP, Proia A, Hollis D, Rizzieri DA (2001) Increased microvessel density in non-Hodgkin's lymphoma (NHL) is localized to the site of disease changes in accordance with disease response. Blood 98: 236b
21. Wróbel T, Mazur G, Surowiak P, Dziegiel P, Zubkiewicz L, Jeleń M (2003) Increased expression of vascular endothelial growth factor (VEGF) in bone marrow of multiple myeloma (MM) patients. Eur J Int Med 14: 98-100